Top

Published in:

01-08-2011 | Review

Clinical review: Thinking outside the box - an iconoclastic view of current practice

Authors: Mervyn Singer, Michael A Matthay

Published in: Critical Care | Issue 4/2011

Abstract

Many advances in medicine have been achieved through challenging established dogma with revolutionary thought and novel practices. Each and every specialty is reinvigorated by regular re-evaluation of processes and practices in the light of new evidence and fresh conceptualization. Challenge can galvanize fresh thinking and new approaches, yet may also reinforce and strengthen traditional paradigms if the prevailing orthodoxy is subsequently revalidated. This article is a synopsis of a roundtable meeting held in Brussels in March 2010 designed specifically to confront doctrine with reasoned scientific argument, and to propose new ideas for advancing critical care practices and outcomes.

Rothwell PM, Lawler PG: Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med. 1995, 23: 78-83. 10.1097/00003246-199501000-00015.PubMedCrossRef

Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, Bellissant E: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000, 283: 1038-1045. 10.1001/jama.283.8.1038.PubMedCrossRef

Hynninen M, Pettilä V, Takkunen O, Orko R, Jansson SE, Kuusela P, Renkonen R, Valtonen M: Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock. 2003, 20: 1-4. 10.1097/01.shk.0000068322.08268.b4.PubMedCrossRef

Levy B, Dusang B, Annane D, Gibot S, Bollaert PE, College Interregional des Réanimateurs du Nord-Est: Cardiovascular response to dopamine and early prediction of outcome in septic shock: A prospective multiple-center study. Crit Care Med. 2005, 33: 2172-2177. 10.1097/01.CCM.0000181297.14319.3C.PubMedCrossRef

Venkatesh B, Morgan TJ, Lipman J: Subcutaneous oxygen tensions provide similar information to ileal luminal CO₂ tensions in an animal model of haemorrhagic shock. Intensive Care Med. 2000, 26: 592-600. 10.1007/s001340051209.PubMedCrossRef

Nandi P, Lunte SM: Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: A review. Anal Chim Acta. 2009, 651: 1-14. 10.1016/j.aca.2009.07.064.PubMedPubMedCentralCrossRef

Cohen J, Venkatesh B: Assessment of tissue cortisol activity. Crit Care Resusc. 2009, 11: 287-289.PubMed

Zeitlinger MA, Dehghanyar P, Mayer BX, Schenk BS, Neckel U, Heinz G, Georgopoulos A, Müller M, Joukhadar C: Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother. 2003, 47: 3548-3553. 10.1128/AAC.47.11.3548-3553.2003.PubMedPubMedCentralCrossRef

Rello J, Lisboa T, Lujan M, Gallego M, Kee C, Kay I, Lopez D, Waterer GW, DNA-Neumococo Study Group: Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest. 2009, 136: 832-840. 10.1378/chest.09-0258.PubMedCrossRef

10.

Kalil AC, Florescu DF: Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med. 2009, 37: 2350-2358. 10.1097/CCM.0b013e3181a3aa43.PubMedCrossRef

11.

Pipilis A, Flather M, Ormerod O, Sleight P: Heart rate variability in acute myocardial infarction and its association with infarct site and clinical course. Am J Cardiol. 1991, 67: 1137-1139. 10.1016/0002-9149(91)90880-T.PubMedCrossRef

12.

Papaioannou V, Giannakou M, Maglaveras N, Sofianos E, Giala M: Investigation of heart rate and blood pressure variability, baroreflex sensitivity, and approximate entropy in acute brain injury patients. J Crit Care. 2008, 23: 380-386. 10.1016/j.jcrc.2007.04.006.PubMedCrossRef

13.

Chen WL, Chen JH, Huang CC, Kuo CD, Huang CI, Lee LS: Heart rate variability measures as predictors of in-hospital mortality in ED patients with sepsis. Am J Emerg Med. 2008, 26: 395-401. 10.1016/j.ajem.2007.06.016.PubMedCrossRef

14.

Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, Gandini G, Herrmann P, Mascia L, Quintel M, Slutsky AS, Gattinoni L, Ranieri VM: Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007, 175: 160-166.PubMedCrossRef

15.

Cressoni M, Zanella A, Epp M, Corti I, Patroniti N, Kolobow T, Pesenti A: Decreasing pulmonary ventilation through bicarbonate ultrafiltration: An experimental study. Crit Care Med. 2009, 37: 2612-2618. 10.1097/CCM.0b013e3181a5668a.PubMedCrossRef

16.

Zanella A, Patroniti N, Isgrò S, Albertini M, Costanzi M, Pirrone F, Scaravilli V, Vergnano B, Pesenti A: Blood acidification enhances carbon dioxide removal of membrane lung: An experimental study. Intensive Care Med. 2009, 35: 1484-1487. 10.1007/s00134-009-1513-5.PubMedCrossRef

17.

Terragni PP, Del Sorbo L, Mascia L, Urbino R, Martin EL, Birocco A, Faggiano C, Quintel M, Gattinoni L, Ranieri VM: Tidal volume lower than 6 ml/kg enhances lung protection: Role of extracorporeal carbon dioxide removal. Anesthesiology. 2009, 111: 826-835. 10.1097/ALN.0b013e3181b764d2.PubMedCrossRef

18.

Hamburger M, Robertson OH: Studies on the pathogenesis of experimental pneumococcus pneumonia in the dog: I. secondary pulmonary lesions. Relationship of bronchial obstruction and distribution of pneumococci to their inception. J Exp Med. 1940, 72: 261-274. 10.1084/jem.72.3.261.PubMedPubMedCentralCrossRef

19.

Robertson OH, Hamburger M: Studies on the pathogenesis of experimental pneumococcus pneumonia in the dog: II. Secondary pulmonary lesions. Their production by intratracheal and intrabronchial injections of fluid pneumonic exudate. J Exp Med. 1940, 72: 275-288. 10.1084/jem.72.3.275.PubMedPubMedCentralCrossRef

20.

Schortgen F, Bouadma L, Joly-Guillou ML, Ricard JD, Dreyfuss D, Saumon G: Infectious and inflammatory dissemination are affected by ventilation strategy in rats with unilateral pneumonia. Intensive Care Med. 2004, 30: 693-701. 10.1007/s00134-003-2147-7.PubMedCrossRef

21.

Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA: Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007, 179: 1855-1863.PubMedCrossRef

22.

Lee JW, Fang X, Gupta N, Serikov V, Matthay MA: Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA. 2009, 106: 16357-16362. 10.1073/pnas.0907996106.PubMedPubMedCentralCrossRef

23.

Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB, Reisman MA, Schaer GL, Sherman W: A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009, 54: 2277-2286. 10.1016/j.jacc.2009.06.055.PubMedPubMedCentralCrossRef

24.

Wigginton JG, Pepe PE, Bedolla JP, DeTamble LA, Atkins JM: Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: A multi-year, prospective, population-based study. Crit Care Med. 2002, 30: S131-136. 10.1097/00003246-200204001-00002.PubMedCrossRef

25.

Yune TY, Kim SJ, Lee SM, Lee YK, Oh YJ, Kim YC, Markelonis GJ, Oh TH: Systemic administration of 17-beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma. 2004, 21: 293-306. 10.1089/089771504322972086.PubMedCrossRef

26.

Hawk T, Zhang YQ, Rajakumar G, Day AL, Simpkins JW: Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats. Brain Res. 1998, 796: 296-298. 10.1016/S0006-8993(98)00327-8.PubMedCrossRef

27.

Barth E, Bassi G, Maybauer DM, Simon F, Gröger M, Oter S, Speit G, Nguyen CD, Hasel C, Möller P, Wachter U, Vogt JA, Matejovic M, Radermacher P, Calzia E: Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med. 2008, 36: 495-503. 10.1097/01.CCM.0B013E318161FC45.PubMedCrossRef

28.

Hauser B, Barth E, Bassi G, Simon F, Gröger M, Oter S, Speit G, Ploner F, Möller P, Wachter U, Vogt JA, Matejovic M, Calzia E, Georgieff M, Radermacher P, Maybauer DM: Hemodynamic, metabolic and organ function effects of pure O₂ ventilation during established fecal peritonitis-induced septic shock. Crit Care Med. 2009, 37: 2465-2469. 10.1097/CCM.0b013e3181aee8ad.PubMedCrossRef

29.

Greif R, Akça O, Horn EP, Kurz A, Sessler DI, Outcomes Research Group: Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection Outcomes Research Group. N Engl J Med. 2000, 342: 161-167. 10.1056/NEJM200001203420303.PubMedCrossRef

30.

Knighton DR, Halliday B, Hunt TK: Oxygen as an antibiotic. The effect of inspired oxygen on infection. Arch Surg. 1984, 119: 199-204.PubMedCrossRef

31.

Kotani N, Hashimoto H, Sessler DI, Muraoka M, Hashiba E, Kubota T, Matsuki A: Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology. 2000, 93: 15-25. 10.1097/00000542-200007000-00008.PubMedCrossRef

32.

Choi H, Kim SH, Chun YS, Cho YS, Park JW, Kim MS: In vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2. Exp Biol Med (Maywood). 2006, 231: 463-472.

33.

Singer M: Catecholamine treatment for shock - equally good or bad?. Lancet. 2007, 370: 636-637. 10.1016/S0140-6736(07)61317-8.PubMedCrossRef

34.

Dünser MW, Takala J, Ulmer H, Mayr VD, Luckner G, Jochberger S, Daudel F, Lepper P, Hasibeder WR, Jakob SM: Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009, 35: 1225-1233. 10.1007/s00134-009-1427-2.PubMedCrossRef

35.

Ackland GL, Yao ST, Rudiger A, Dyson A, Stidwill R, Poputnikov D, Singer M, Gourine AV: Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med. 2010, 38: 388-394. 10.1097/CCM.0b013e3181c03dfa.PubMedCrossRef

36.

Hagiwara S, Iwasaka H, Maeda H, Noguchi T: Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock. 2009, 31: 515-520. 10.1097/SHK.0b013e3181863689.PubMedCrossRef

37.

Gore DC, Wolfe RR: Hemodynamic and metabolic effects of selective beta-1 adrenergic blockade during sepsis. Surgery. 2006, 139: 686-694. 10.1016/j.surg.2005.10.010.PubMedCrossRef

38.

Schmittinger CA, Dünser MW, Haller M, Ulmer H, Luckner G, Torgersen C, Jochberger S, Hasibeder WR: Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care. 2008, 12: R99-10.1186/cc6976.PubMedPubMedCentralCrossRef

39.

McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med. 1998, 338: 171-179. 10.1056/NEJM199801153380307.PubMedCrossRef

40.

Sterling P: Principles of allostasis: Optimal design, predictive regulation, pathophysiology, and rational therapeutics. Allostasis, Homeostasis, and the Costs of Physiological Adaptation. Edited by: Schulkin J. 2004, Cambridge, UK: Cambridge University Press

41.

Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC: Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005, 352: 539-548. 10.1056/NEJMoa043046.PubMedCrossRef

42.

Selye H: Stress and the general adaptation syndrome. Br Med J. 1950, 1: 1383-1392. 10.1136/bmj.1.4667.1383.PubMedPubMedCentralCrossRef

43.

Singer M, De Santis V, Vitale D, Jeffcoate W: Multiorgan failure is an adaptive, endocrinemediated, metabolic response to overwhelming systemic inflammation. Lancet. 2004, 364: 545-548. 10.1016/S0140-6736(04)16815-3.PubMedCrossRef

44.

Friese RS, Bruns B, Sinton CM: Sleep deprivation after septic insult increases mortality independent of age. J Trauma. 2009, 66: 50-54. 10.1097/TA.0b013e318190c3a1.PubMedCrossRef

45.

Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, Gordon SM, Canonico AE, Dittus RS, Bernard GR, Ely EW: Duration of delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010, 38: 1513-1520. 10.1097/CCM.0b013e3181e47be1.PubMedPubMedCentralCrossRef

46.

Sampson EL, Raven PR, Ndhlovu PN, Vallance A, Garlick N, Watts J, Blanchard MR, Bruce A, Blizard R, Ritchie CW: A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int J Geriatr Psychiatry. 2007, 22: 343-349. 10.1002/gps.1679.PubMedCrossRef

47.

Singer M, Glynne P: Treating critical illness: the importance of first doing no harm. PLoS Med. 2005, 2: e167-10.1371/journal.pmed.0020167.PubMedPubMedCentralCrossRef

48.

Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP: Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial. Lancet. 2009, 373: 1874-1882. 10.1016/S0140-6736(09)60658-9.PubMedCrossRef

49.

Yuan CS, Wei G, Foss JF, O'Connor M, Karrison T, Osinski J: Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: A double-blind randomized placebo-controlled trial. J Pharmacol Exp Ther. 2002, 300: 118-123. 10.1124/jpet.300.1.118.PubMedCrossRef

50.

Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG, SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA. 2009, 301: 489-499. 10.1001/jama.2009.56.PubMedCrossRef

51.

De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphaël JC, Outin H, Bastuji-Garin S, Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA. 2002, 288: 2859-2867. 10.1001/jama.288.22.2859.PubMedCrossRef

52.

Léger B, Senese R, Al-Khodairy AW, Dériaz O, Gobelet C, Giacobino JP, Russell AP: Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve. 2009, 40: 69-78. 10.1002/mus.21293.PubMedCrossRef

53.

Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R: The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996, 335: 1-7. 10.1056/NEJM199607043350101.PubMedCrossRef

54.

Vivodtzev I, Pépin JL, Vottero G, Mayer V, Porsin B, Lévy P, Wuyam B: Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest. 2006, 129: 1540-1548. 10.1378/chest.129.6.1540.PubMedCrossRef

55.

Ospina-Tascon GA, Buchele GL, Vincent JL: Multicenter, randomized, controlled trials evaluating mortality in intensive care: Doomed to fail?. Crit Care Med. 2008, 36: 1311-1322. 10.1097/CCM.0b013e318168ea3e.PubMedCrossRef

56.

Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR, SAPS 3 Investigators: SAPS 3. From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005, 31: 1345-1355. 10.1007/s00134-005-2763-5.PubMedPubMedCentralCrossRef

57.

Moreno RP, Metnitz B, Adler L, Hoechtl A, Bauer P, Metnitz PG, SAPS 3 Investigators: Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med. 2008, 34: 496-504. 10.1007/s00134-007-0943-1.PubMedCrossRef

58.

Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000, 342: 1878-1886. 10.1056/NEJM200006223422506.PubMedCrossRef

59.

Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000, 342: 1887-1892. 10.1056/NEJM200006223422507.PubMedPubMedCentralCrossRef

60.

Cresci G, Cue J: The patient with circulatory shock: to feed or not to feed?. Nutr Clin Pract. 2008, 23: 501-509. 10.1177/0884533608323431.PubMedCrossRef

61.

Pronovost PJ, Jenckes MW, Dorman T, Garrett E, Breslow MJ, Rosenfeld BA, Lipsett PA, Bass E: Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA. 1999, 281: 1310-1317. 10.1001/jama.281.14.1310.PubMedCrossRef

Title: Clinical review: Thinking outside the box - an iconoclastic view of current practice
Authors: Mervyn Singer
Michael A Matthay
Publication date: 01-08-2011
Publisher: BioMed Central
Published in: Critical Care / Issue 4/2011
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc10245

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Clinical review: Thinking outside the box - an iconoclastic view of current practice

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

Women receive more trials of noninvasive ventilation for acute respiratory failure than men: a nationwide population-based study

A novel use for novel acute kidney injury biomarkers: fenoldopam's effect on neutrophil gelatinase-associated lipocalin and cystatin C

Clinical review: Special populations - critical illness and pregnancy

High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality

PaCO2 and alveolar dead space are more relevant than PaO2/FiO2 ratio in monitoring the respiratory response to prone position in ARDS patients: a physiological study

O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management?